{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T14:05:58Z","timestamp":1777557958651,"version":"3.51.4"},"reference-count":21,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Diabetes &amp; Vascular Disease Research"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Colchicine is effective for secondary prevention of major adverse cardiovascular events (MACE), yet its benefit in individuals with diabetes remains uncertain despite their elevated cardiovascular risk. This systematic review and meta-analysis assessed the impact of colchicine on cardiovascular outcomes in individuals with diabetes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Databases were searched from inception to November 2024 for randomized controlled trials assessing colchicine for reducing MACE. A meta-analysis was performed using RevMan 5.4 with a fixed-effects inverse-variance model to generate pooled risk ratios (RR, HR). PROSPERO registration: CRD42024575366.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Five RCTs were included, comprising 2977 participants with diabetes (1492 (50%) colchicine; 1485 (50%) placebo\/usual care). Most were males over 60 years. Colchicine significantly reduced MACE, HR 0.79 (95% CI 0.67\u20130.94, p = 0.006). Subgroup analysis of diabetic versus non-diabetic participants yielded a similar effect, HR 0.75 (95% CI 0.67\u20130.83, p &lt; 0.001). Colchicine did not increase adverse events: composite events RR 0.81 (95% CI 0.68\u20130.96;\u00a0\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u00a0= 0.02), gastrointestinal events RR 1.09 (95% CI 0.98\u20131.20, p = 0.12), or musculoskeletal events RR 0.77 (95% CI 0.43\u20131.38, p = 0.39). Benefits were observed with 0.5\u00a0mg daily over a median 28.6 months.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Colchicine is associated with a reduction in major cardiovascular events in individuals with diabetes, with consistent long-term benefit at low doses without an increase in adverse effects.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/14791641261418934","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T07:50:50Z","timestamp":1774597850000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of colchicine for secondary prevention of cardiovascular diseases in individuals with diabetes: A meta-analysis of randomized trials"],"prefix":"10.1177","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7075-4081","authenticated-orcid":false,"given":"Niludi Ranwanee","family":"Yasaratna","sequence":"first","affiliation":[{"name":"Monash University"},{"name":"Community Medicine, Post Graduate Institute of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danushi","family":"Wijekoon","sequence":"additional","affiliation":[{"name":"Community Medicine, Post Graduate Institute of Medicine"},{"name":"Research Unit, Melbourne Sexual Health Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Claude","family":"Tardif","sequence":"additional","affiliation":[{"name":"Department of Medicine, Montreal Heart Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Reid","sequence":"additional","affiliation":[{"name":"Monash University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"key":"e_1_3_8_2_2","volume-title":"Fact sheet 2022","author":"WHO. Noncommunicable diseases","year":"2022","unstructured":"WHO. Noncommunicable diseases. Fact sheet 2022. World Health Organization, 2022."},{"key":"e_1_3_8_3_2","doi-asserted-by":"publisher","DOI":"10.1177\/2047487319878371"},{"key":"e_1_3_8_4_2","doi-asserted-by":"publisher","DOI":"10.2174\/1871523011312010004"},{"key":"e_1_3_8_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2015.06.013"},{"key":"e_1_3_8_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-021-02639-6"},{"key":"e_1_3_8_7_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2024.1356023"},{"key":"e_1_3_8_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n160"},{"key":"e_1_3_8_9_2","volume-title":"Review manager (RevMan) [computer program]. Version 5.4","author":"Cochrane Collaboration","year":"2020","unstructured":"Cochrane Collaboration. Review manager (RevMan) [computer program]. Version 5.4. The Nordic Cochrane Centre, 2020."},{"key":"e_1_3_8_10_2","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins JPT","year":"2024","unstructured":"Higgins JPT, Thomas J, Chandler J, et al. (eds). Cochrane Handbook for Systematic Reviews of Interventions. John Wiley & Sons, 2024. Version 6.5."},{"key":"e_1_3_8_11_2","volume-title":"IBM SPSS statistics for windows [computer program]. Version 27.0. armonk (NY)","author":"IBM Corp","year":"2020","unstructured":"IBM Corp. IBM SPSS statistics for windows [computer program]. Version 27.0. armonk (NY). IBM Corp, 2020."},{"key":"e_1_3_8_12_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc23-1825"},{"key":"e_1_3_8_13_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1244529"},{"key":"e_1_3_8_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.01.055"},{"key":"e_1_3_8_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.050771"},{"key":"e_1_3_8_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.10.027"},{"key":"e_1_3_8_17_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.947959"},{"key":"e_1_3_8_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102835"},{"key":"e_1_3_8_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-021-01056-z"},{"key":"e_1_3_8_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-021-02654-7"},{"key":"e_1_3_8_21_2","doi-asserted-by":"publisher","DOI":"10.34172\/jrip.2020.28"},{"key":"e_1_3_8_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)00968-1"}],"container-title":["Diabetes &amp; Vascular Disease Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/14791641261418934","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/14791641261418934","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/14791641261418934","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:20:20Z","timestamp":1777400420000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/14791641261418934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1177\/14791641261418934"],"URL":"https:\/\/doi.org\/10.1177\/14791641261418934","relation":{},"ISSN":["1479-1641","1752-8984"],"issn-type":[{"value":"1479-1641","type":"print"},{"value":"1752-8984","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]},"article-number":"14791641261418934"}}